These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 683909)
1. The effects of potassium supplements, spironolactone of amiloride on the potassium status of patients with heart failure. Davidson C; Burkinshaw L; Morgan DB Postgrad Med J; 1978 Jun; 54(632):405-9. PubMed ID: 683909 [TBL] [Abstract][Full Text] [Related]
2. [The problem of potassium and diuretics]. Bernik V Rev Paul Med; 1972 Sep; 80(3):127-32. PubMed ID: 4602416 [No Abstract] [Full Text] [Related]
3. Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure. Nicholls MG; Espiner EA; Hughes H; Rogers T Br Heart J; 1976 Oct; 38(10):1025-30. PubMed ID: 973876 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of cardiac failure with diuretics. A double-blind study comparing a fixed combination of hydrochlorothiazide/amiloride and furosemide plus potassium substitution]. Kremer D Tidsskr Nor Laegeforen; 1983 May; 103(14):1165-8. PubMed ID: 6349006 [No Abstract] [Full Text] [Related]
6. Spironolactone and amiloride in hypertensive patients with and without aldosterone excess. Hoefnagels WH; Drayer JI; Smals AG; Kloppenborg PW Clin Pharmacol Ther; 1980 Mar; 27(3):317-23. PubMed ID: 6987022 [No Abstract] [Full Text] [Related]
7. [Potassium depletion in cardiology. Action of amiloride, a potassium sparing diuretic]. Chapelle M; Chiche P Acta Cardiol; 1973; 28(3):347-57. PubMed ID: 4543132 [No Abstract] [Full Text] [Related]
8. Comparison of the potassium- retaining effects of amiloride and spironolactone in hypertensive patients with thiazide-induced hypokalaemia. George CF; Breckenridge AM; Dollery CT Lancet; 1973 Dec; 2(7841):1288-91. PubMed ID: 4127641 [No Abstract] [Full Text] [Related]
9. Exchangeable potassium in heart disease: long-term effects of potassium supplements and amiloride. Croxson MS; Neutze JM; John MB Am Heart J; 1972 Jul; 84(1):53-60. PubMed ID: 5080282 [No Abstract] [Full Text] [Related]
11. Some aspects of diuretic therapy. Rowe WS Med J Aust; 1975 Mar; 1(12):392-4. PubMed ID: 1143129 [No Abstract] [Full Text] [Related]
12. Diuretics, cardiac failure and potassium depletion: a rational approach. Whight C; Morgan T; Carney S; Wilson M Med J Aust; 1974 Dec; 2(23):831-3. PubMed ID: 4217884 [No Abstract] [Full Text] [Related]
13. [Comparison of spironolactone and amiloride combined with hydrochlorothiazide in the treatment of slight or moderate hypertension]. Sanguigni D; Benvenuti C Clin Ter; 1978 Oct; 87(1):69-74. PubMed ID: 737980 [No Abstract] [Full Text] [Related]
14. [Use and abuse of potassium-saving diuretics]. Berg KJ Tidsskr Nor Laegeforen; 1979 Mar; 99(8):436-7. PubMed ID: 432873 [No Abstract] [Full Text] [Related]
15. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial. Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789 [TBL] [Abstract][Full Text] [Related]
17. An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study. Allman S; Norris RJ J Int Med Res; 1990; 18 Suppl 2():17B-23B. PubMed ID: 2193840 [TBL] [Abstract][Full Text] [Related]
18. Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes. Kremer D; Beevers DG; Brown JJ; Davies DL; Ferriss JB; Fraser R; Lever AF; Robertson JI Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():213s-8. PubMed ID: 4361398 [No Abstract] [Full Text] [Related]
19. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil. Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294 [TBL] [Abstract][Full Text] [Related]
20. Paradoxical reversal of the suppressed potassium secretion during treatment with combinations of antikaluretic agents (spironolactone, canrenone, triamterene, amiloride); a possible site of action in Henle's loop. Radó JP; Sawinsky I; Juhos E Horm Metab Res; 1976 May; 8(3):250-1. PubMed ID: 939474 [No Abstract] [Full Text] [Related] [Next] [New Search]